| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | BPZ4A29SYE |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Huntington Disease | 2 | D006816 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Osteosarcoma | 1 | D012516 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
| Alzheimer Disease | 1 | D000544 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297884 |
| FDA SRS | BPZ4A29SYE |
CONTENTS